Search company, investor...


Founded Year



Series A | Alive

Total Raised


Last Raised

$4.48M | 4 yrs ago

About AbTis

AbTis (앱티스) is a bio-venture company focused on drug development for anti-aging applications.

Headquarters Location


South Korea

Missing: AbTis's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: AbTis's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Expert Collections containing AbTis

Expert Collections are analyst-curated lists that highlight the companies you need to know in the most important technology spaces.

AbTis is included in 1 Expert Collection, including Biopharma Tech.


Biopharma Tech

5,241 items

Companies involved in the research, development, and commercialization of chemically- or biologically-derived therapeutic & theranostic drugs. Excludes vitamins/supplements, CROs/clinical trial services.

AbTis Patents

AbTis has filed 1 patent.

The 3 most popular patent topics include:

  • Alkenoic acids
  • Biotechnology
  • Carboxylic acids
patents chart

Application Date

Grant Date


Related Topics




Fatty acids, Alkenoic acids, Carboxylic acids, Vegetable oils, Nutrition


Application Date


Grant Date



Related Topics

Fatty acids, Alkenoic acids, Carboxylic acids, Vegetable oils, Nutrition



Latest AbTis News

WuXi XDC, AbTis sign MoU to develop ADC products

Jul 11, 2022

The company is a joint venture between WuXi Biologics and WuXi STA and provides end-to-end contract research, development, and manufacturing of bioconjugates, such as ADCs. Under the terms The post WuXi XDC, AbTis sign MoU to develop ADC products appeared first on Pharmaceutical Business review.

AbTis Frequently Asked Questions (FAQ)

  • When was AbTis founded?

    AbTis was founded in 2016.

  • Where is AbTis's headquarters?

    AbTis's headquarters is located at Seoul.

  • What is AbTis's latest funding round?

    AbTis's latest funding round is Series A.

  • How much did AbTis raise?

    AbTis raised a total of $4.48M.

  • Who are the investors of AbTis?

    Investors of AbTis include K2 Investment Partners, JX Partners and Stonebridge Ventures.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.